Treatment.com AI Inc. Stock

Equities

TRUE

CA8949421017

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 03:58:47 2024-04-12 pm EDT 5-day change 1st Jan Change
0.69 CAD -1.43% Intraday chart for Treatment.com AI Inc. +4.55% +62.35%
Sales 2021 - Sales 2022 - Capitalization 3.31M 4.56M
Net income 2021 -13M -17.9M Net income 2022 -3M -4.13M EV / Sales 2021 -
Net cash position 2021 917K 1.26M Net Debt 2022 564K 776K EV / Sales 2022 -
P/E ratio 2021
-3.84 x
P/E ratio 2022
-0.87 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 95.22%
More Fundamentals * Assessed data
Dynamic Chart
Treatment.com AI Partnering With aiXplain Inc. to Extend Access to its Global Library of Medicine MT
Treatment.com AI Inc.'s AI Medical Information Support Platform Uses in the Objective Structured Clinical Examination CI
Treatment.com AI Inc. announced that it has received CAD 2.9082 million in funding CI
Treatment.com AI Inc. announced that it expects to receive CAD 2 million in funding CI
Treatment.com AI Inc. Announces the Resignation of John Fraser from the Board of Directors CI
Treatment.Com Ai Inc. Appoints David Worner as Chief Financial Officer CI
Treatment.com AI Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Treatment.com International Inc. will Change its Name to Treatment.com AI Inc CI
Treatment.Com International Inc. Appoints Kevin Peterson as Chief Medical Officer CI
Treatment.Com International Inc. Appoints Dr. Essam Hamza, MD as Chief Executive Officer CI
Treatment.Com International Inc. Appoints Dr. Essam Hamza, Md to its Board of Directors CI
Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding CI
Treatment.Com International Inc. announced that it has received CAD 1 million in funding CI
Treatment.Com International Inc. announced that it expects to receive CAD 0.5 million in funding CI
Treatment.com AI Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news
1 day-1.43%
1 week+4.55%
Current month+15.00%
1 month+27.78%
3 months+46.81%
6 months+206.67%
Current year+62.35%
More quotes
1 week
0.59
Extreme 0.59
0.75
1 month
0.51
Extreme 0.51
0.75
Current year
0.44
Extreme 0.44
0.75
1 year
0.10
Extreme 0.1
1.20
3 years
0.10
Extreme 0.1
63.00
5 years
0.10
Extreme 0.1
63.00
10 years
0.10
Extreme 0.1
63.00
More quotes
Managers TitleAgeSince
Founder 70 15-12-31
Chief Executive Officer 53 23-10-16
Director of Finance/CFO 45 Feb. 04
Members of the board TitleAgeSince
Director/Board Member 45 21-01-17
Chief Executive Officer 53 23-10-16
Founder 70 15-12-31
More insiders
Date Price Change Volume
24-04-12 0.69 -1.43% 169,934
24-04-11 0.7 -4.11% 93,801
24-04-10 0.73 +5.80% 597,179
24-04-09 0.69 +9.52% 578,977
24-04-08 0.63 -4.55% 41,855

Delayed Quote Canadian Securities Exchange, April 12, 2024 at 03:58 pm EDT

More quotes
Treatment.com AI Inc., formerly Treatment.com International Inc., is a global healthcare company. The Company has developed an artificial intelligence (AI) platform to help patients and caregivers make health decisions. The Company offers Treatment Digital Health App. The Treatment Digital Health App is a symptom assessment tool, built and updated by a global team of doctors and engineers to provide users with predictive and accurate insights about their health. The App provides advanced access to medical knowledge available for widespread use. The Treatment Digital Health App’s health assessments results are generated using estimates of disease rates, current estimates of geographic variation, and medical research. It offers solutions in medical education, medical clinic, and clinical advisor.
More about the company